Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous vs Systemic Cefazolin in Total Knee Arthroplasty
NCT02433704Phase 4Withdrawn
- Sponsor
- Duke University
- Start
- May 2015
- Primary completion
- May 2017
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin in surgical site infection (SSI), sponsored by Duke University. Planned start May 2015; status: withdrawn.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02433704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02433704.